NASDAQ: INMD

Inmode Ltd Stock Forecast, Predictions & Price Target

The consensus among 3 Wall Street analysts covering (NASDAQ: INMD) stock is to Buy INMD stock.

Out of 3 analysts, 1 (33.33%) are recommending INMD as a Strong Buy, 0 (0%) are recommending INMD as a Buy, 2 (66.67%) are recommending INMD as a Hold, 0 (0%) are recommending INMD as a Sell, and 0 (0%) are recommending INMD as a Strong Sell.

If you're new to stock investing, here's how to buy Inmode stock.

(NASDAQ: INMD) Inmode's forecast annual revenue growth rate of 2.2% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.43%.

Inmode's revenue in 2024 is $492,048,000.On average, 1 Wall Street analysts forecast INMD's revenue for 2024 to be $40,529,936,161, with the lowest INMD revenue forecast at $40,529,936,161, and the highest INMD revenue forecast at $40,529,936,161. On average, 1 Wall Street analysts forecast INMD's revenue for 2025 to be $43,158,587,222, with the lowest INMD revenue forecast at $43,158,587,222, and the highest INMD revenue forecast at $43,158,587,222.

In 2026, INMD is forecast to generate $45,787,238,282 in revenue, with the lowest revenue forecast at $45,787,238,282 and the highest revenue forecast at $45,787,238,282.

According to 3 Wall Street analysts that have issued a 1 year INMD price target, the average INMD price target is $27.00, with the highest INMD stock price forecast at $33.00 and the lowest INMD stock price forecast at $22.00.

On average, Wall Street analysts predict that Inmode's share price could reach $27.00 by Apr 12, 2025. The average Inmode stock price prediction forecasts a potential upside of 54.73% from the current INMD share price of $17.45.

(NASDAQ: INMD) forecast ROE is N/A, which is considered weak.